Verified peer comparison
Vistagen Therapeutics, Inc. vs China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares Financial Comparison
Vistagen Therapeutics, Inc. versus China SXT Pharmaceuticals, Inc. - Class A Or…
Direct answer
Vistagen Therapeutics, Inc. and China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares are compared on the same basis.
The comparison uses 2026 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Vistagen Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Vistagen Therapeutics, Inc. Revenue
- 1,269,000 USD
- China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares Revenue
- 1,072,632 USD
- Vistagen Therapeutics, Inc. Operating income
- -72,126,000 USD
- China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares Operating income
- -7,122,933 USD